Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Battelli

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Clinical Drug Investigation|April 3, 2019
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the RevolutionVeronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Critical Reviews in Oncology/Hematology|June 19, 2022
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survivalMatteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, et al.
Cancers|April 3, 2019
The Human Microbiota and Prostate Cancer: Friend or Foe?Francesco Massari, Veronica Mollica, Vincenzo Di Nunno, et al.
Frontiers in Oncology|September 28, 2020
Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung CancerMarco Maria Aiello, Cinzia Solinas, Matteo Santoni, et al.
Future Oncology (London, England)|December 11, 2020
Predicting future cancer burden in the United States by artificial neural networksFrancesco Piva, Francesca Tartari, Matteo Giulietti, et al.
Cancers|July 1, 2014
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associationsMirco Pistelli, Miriam Caramanti, Tommasina Biscotti, et al.
Frontiers in Genetics|May 1, 2020
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical ImplicationsGiulia Occhipinti, Emanuela Romagnoli, Matteo Santoni, et al.
Cancers|August 25, 2019
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate CancersMatteo Santoni, Alessia Cimadamore, Francesco Massari, et al.
American Journal of Clinical Oncology|August 8, 2006
Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodesNicola Battelli, Cristian Massacesi, Chiara Braconi, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2023
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysisMatteo Santoni, Alessandro Rizzo, Jakub Kucharz, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Clinical Drug Investigation|April 3, 2019
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the RevolutionVeronica Mollica, Vincenzo Di Nunno, Lidia Gatto, et al.
Critical Reviews in Oncology/Hematology|June 19, 2022
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survivalMatteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, et al.
Cancers|April 3, 2019
The Human Microbiota and Prostate Cancer: Friend or Foe?Francesco Massari, Veronica Mollica, Vincenzo Di Nunno, et al.
Frontiers in Oncology|September 28, 2020
Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung CancerMarco Maria Aiello, Cinzia Solinas, Matteo Santoni, et al.
Future Oncology (London, England)|December 11, 2020
Predicting future cancer burden in the United States by artificial neural networksFrancesco Piva, Francesca Tartari, Matteo Giulietti, et al.
Cancers|July 1, 2014
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associationsMirco Pistelli, Miriam Caramanti, Tommasina Biscotti, et al.
Frontiers in Genetics|May 1, 2020
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical ImplicationsGiulia Occhipinti, Emanuela Romagnoli, Matteo Santoni, et al.
Cancers|August 25, 2019
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate CancersMatteo Santoni, Alessia Cimadamore, Francesco Massari, et al.
American Journal of Clinical Oncology|August 8, 2006
Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodesNicola Battelli, Cristian Massacesi, Chiara Braconi, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2023
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysisMatteo Santoni, Alessandro Rizzo, Jakub Kucharz, et al.
Pageof 9